PTGS2 and rheumatoid arthritis: Several pharmacological studies conducted on eicosanoids have given the genetic evidence of PGs and COX-2, in development of autoimmune diseases including rheumatoid arthritis (RA) (Minghetti, 2004; Lucas et al., 2006).